Skip to main content
. 2021 Mar 23;10(3):342. doi: 10.3390/antibiotics10030342

Table 3.

Clinical and epidemiological characteristics of CHG-tolerant vs. CHG-susceptible isolates.

Characteristic Reduced Susceptibility to CHG Total
Isolates
n = 190
n (%)
p-Value 1
Yes
n = 25
n (%)
No
n = 165
n (%)
qac A/B presence <0.0001 2
Yes 10 (40) 15 (60) 25
No 15 (9) 150 (81) 165
Methicillin susceptibility <0.0001
Resistant (MRSA) 22 (24) 70 (76) 92
Sensitive (MSSA) 3 (3) 95 (97) 98
Mupirocin susceptibility 0.001
Resistant 7 (39) 11 (61) 18
Sensitive 18 (10.5) 154 (89.5) 172
Mupirocin’s MIC (mg/L) 0.066
Mean 257.44 69.74 94.45
Median (Q1, Q3) 0.19 (0.125, 256) 0.064 (0.094, 0.25) 0.125 (0.094, 0.25)
pvl presence 0.548
Yes 4 (10.25) 35 (89.75) 39
No 21 (12.3) 130 (87.7) 171
Sample source 0.020
Blood culture 14 (21) 53 (79) 67
Wounds 11 (8.95) 112 (91.05) 123

1 Chi-squared test, Mann–Whitney test. 2 Bold values indicate statistical significance.